Oral Ph Sensitive GNS@ab Nanoprobes for Targeted Therapy of Helicobacter Pylori Without Disturbance Gut Microbiome.

Xiao Zhi,Yanlei Liu,Lingnan Lin,Meng Yang,Lingxia Zhang,Li Zhang,Yangtian Liu,Gabriel. Alfranca,Lijun Ma,Qian Zhang,Hualin Fu,Joao Conde,Xianting Ding,Di Chen,Jian Ni,Jie Song,Daxiang Cui

DOI: https://doi.org/10.1016/j.nano.2019.102019

2019-01-01

Abstract:How to eradicate Helicobacter pylori (H. pylori) in vivo with antibiotic resistance owns tremendous clinical requirement. Herein, gold nanostars were conjugated with acid-sensitive cis-aconitic anhydride modified anti-H. pylori polyclonal antibodies, resultant pH sensitive gold nanostars@H. pylori-antibodies nanoprobes (GNS@Ab) were employed for the theranostics of H. pylori in vivo. Photoacoustic imaging confirmed that prepared GNS@Ab could target actively H. pylori in the stomach. GNS@Ab nanoprobes could kill H. pylori in vivo in model animals under NIR laser irradiation, all GNS@Ab nanoprobes could be excreted out of gut within 7 days after oral administration. Gastric local lesion caused by H. pylori restored to normal status within one month. GNS@Ab nanoprobes within therapeutic doses did not damage intestinal bacteria imbalance. Forty clinical specimens of H. pylori with antibiotic resistance were verified validity of GNS@Ab nanoprobes. Prepared oral pH-sensitive GNS@Ab nanoprobes own clinical translational potential in the theranostics of H. pylori in near future.